Brentuximab vedotin‐containing regimen time toxicity for front‐line therapy of advanced‐stage classical Hodgkin lymphoma in young adults and adults: Real‐life comparison between condensed BrECADD versus traditional Bv + AVD / Picardi, M., Vincenzi, A., Pane, F.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - (2026). [10.1111/bjh.70917]

Brentuximab vedotin‐containing regimen time toxicity for front‐line therapy of advanced‐stage classical Hodgkin lymphoma in young adults and adults: Real‐life comparison between condensed BrECADD versus traditional Bv + AVD

Picardi, Marco;Vincenzi, Annamaria
;
Pane, Fabrizio
2026

2026
Brentuximab vedotin‐containing regimen time toxicity for front‐line therapy of advanced‐stage classical Hodgkin lymphoma in young adults and adults: Real‐life comparison between condensed BrECADD versus traditional Bv + AVD / Picardi, M., Vincenzi, A., Pane, F.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - (2026). [10.1111/bjh.70917]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1075594
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact